You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康恩貝(600572.SH):鹽酸坦索羅辛緩釋膠囊、非那雄胺片擬中標全國藥品集採
格隆匯 08-20 18:37

格隆匯 8 月 20日丨康恩貝(600572.SH)公佈,根據《國務院辦公廳關於印發國家組織藥品集中採購和使用試點方案》(國辦發【2019】2號)和《國家醫療保障局等九部門關於國家組織藥品集中採購和使用試點擴大區域範圍的實施意見》(醫保發〔2019〕56號)有關精神,聯合採購辦公室開展第三批國家組織藥品集中採購和使用工作。

根據公司統籌安排,2020年8月20日,公司已通過國家藥品監督管理局仿製藥質量和療效一致性評價的鹽酸坦索羅辛緩釋膠囊、非那雄胺片和布洛芬顆粒參加了第三批全國藥品集中採購的投標。經聯合採購辦公室開標、評標後,鹽酸坦索羅辛緩釋膠囊、非那雄胺片擬中標本次集中採購。

目前,公司已與聯合採購辦公室簽訂了《全國藥品集中採購擬中選品種備忘錄》。上述產品的採購合同簽訂等後續事項尚具有不確定性。公司將密切關注該事項的進展情況並及時履行信息披露義務,敬請廣大投資者謹慎決策,注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account